Welcome to HCC-TAG! Our mission is to bring the latest updates in
therapeutic developments in HCC from leading researchers in the field in an
interactive, multidisciplinary format. Our directors and scientific advisory
board members are experts in the field of HCC within the fields of
hepatology, surgery, oncology and interventional oncology.

The HCC-TAG conference is designed to bring together clinicians and
researchers in academia and the pharmaceutical industry for a focused
interactive educational update highlighting the most relevant advances and
challenges in the diagnosis and therapy of HCC. This single topic conference
will take place over two days, providing attendees with an understanding of
current and future directions in diagnostic procedures, prospects and
challenges in drug discovery and development for HCC. Internationally
renowned faculty will assist in the development of the educational content
and will serve as faculty at the conference.

Sincerely,
Anjana Pillai, MD
Associate Professor of Medicine
University of Chicago Medicine

Michael Charlton, MD
Professor of Medicine
University of Chicago Medicine